{"id":"https://openalex.org/W2473218705","doi":"https://doi.org/10.1001/jamaoncol.2016.1051","title":"Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review","display_name":"Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review","publication_year":2016,"publication_date":"2016-07-01","ids":{"openalex":"https://openalex.org/W2473218705","doi":"https://doi.org/10.1001/jamaoncol.2016.1051","mag":"2473218705","pmid":"https://pubmed.ncbi.nlm.nih.gov/27367787"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2016.1051","doi":"https://doi.org/10.1001/jamaoncol.2016.1051","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.1051","pdf_url":null,"source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2473218705"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004706727","display_name":"Claire Frances Friedman","orcid":"https://orcid.org/0000-0003-2621-8553","observed_orcids":["https://orcid.org/0000-0003-2621-8553"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claire F. Friedman","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York","Weill Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112386471","display_name":"Tracy Ann Proverbs-Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracy A. Proverbs-Singh","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York","Weill Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011325668","display_name":"Michael Andrew Postow","orcid":"https://orcid.org/0000-0002-3367-7961","observed_orcids":["https://orcid.org/0000-0002-3367-7961"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Postow","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York","Weill Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":42.006,"has_fulltext":false,"cited_by_count":814,"citation_normalized_percentile":{"value":0.99852163,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"2","issue":"10","first_page":"1346","last_page":"1346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9620000123977661},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":1.0},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9449999928474426},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6650000214576721},{"id":"https://openalex.org/keywords/corticosteroid-induced-immunosuppression","display_name":"corticosteroid immunosuppression","score":0.7749999761581421},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9169999957084656},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.4880000054836273},{"id":"https://openalex.org/keywords/colitis","display_name":"colitis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hepatitis","display_name":"hepatitis","score":0.9679999947547913},{"id":"https://openalex.org/keywords/endocrine-disorders","display_name":"endocrine disorders","score":0.9279999732971191},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.9779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.921475887298584},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8570798635482788},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8174259662628174},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5688291788101196},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.563431441783905},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.5600427985191345},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5314596891403198},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4923757314682007},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.44886648654937744},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4241222143173218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3563922047615051},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.34691303968429565},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jamaoncol.2016.1051","doi":"https://doi.org/10.1001/jamaoncol.2016.1051","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.1051","pdf_url":null,"source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmid:27367787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27367787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":71,"referenced_works":["https://openalex.org/W865168492","https://openalex.org/W1556990476","https://openalex.org/W1605630196","https://openalex.org/W1913801405","https://openalex.org/W1914776013","https://openalex.org/W1973613923","https://openalex.org/W1976743909","https://openalex.org/W1982488143","https://openalex.org/W1984592499","https://openalex.org/W1990675339","https://openalex.org/W1999266721","https://openalex.org/W2001136531","https://openalex.org/W2009942530","https://openalex.org/W2022073464","https://openalex.org/W2022430110","https://openalex.org/W2029073555","https://openalex.org/W2034392291","https://openalex.org/W2048296690","https://openalex.org/W2049827204","https://openalex.org/W2056085563","https://openalex.org/W2065101370","https://openalex.org/W2068594961","https://openalex.org/W2070753851","https://openalex.org/W2070825440","https://openalex.org/W2079713973","https://openalex.org/W2080759679","https://openalex.org/W2086264703","https://openalex.org/W2095267413","https://openalex.org/W2096511276","https://openalex.org/W2097995306","https://openalex.org/W2100127605","https://openalex.org/W2105057287","https://openalex.org/W2107484016","https://openalex.org/W2109653150","https://openalex.org/W2116548718","https://openalex.org/W2116607009","https://openalex.org/W2119198740","https://openalex.org/W2122096722","https://openalex.org/W2123264723","https://openalex.org/W2123363005","https://openalex.org/W2124319844","https://openalex.org/W2125616358","https://openalex.org/W2128035403","https://openalex.org/W2128758225","https://openalex.org/W2129540272","https://openalex.org/W2132916434","https://openalex.org/W2135707184","https://openalex.org/W2137349687","https://openalex.org/W2138134458","https://openalex.org/W2140254549","https://openalex.org/W2140521678","https://openalex.org/W2143163879","https://openalex.org/W2143488876","https://openalex.org/W2145758369","https://openalex.org/W2148706732","https://openalex.org/W2152897456","https://openalex.org/W2152980179","https://openalex.org/W2153942285","https://openalex.org/W2156353875","https://openalex.org/W2160834915","https://openalex.org/W2162519330","https://openalex.org/W2166107256","https://openalex.org/W2166662937","https://openalex.org/W2198093519","https://openalex.org/W2222086386","https://openalex.org/W2289712604","https://openalex.org/W2313175236","https://openalex.org/W2325469667","https://openalex.org/W2336119057","https://openalex.org/W2397678426","https://openalex.org/W2596303604"],"related_works":["https://openalex.org/W2259730793","https://openalex.org/W2914121545","https://openalex.org/W2983304924","https://openalex.org/W2991338574","https://openalex.org/W2370787112","https://openalex.org/W1605630196","https://openalex.org/W2125082756","https://openalex.org/W3110156368","https://openalex.org/W3014279612","https://openalex.org/W2940105550"],"abstract_inverted_index":{"IMPORTANCE:":[0],"The":[1,115,152,179],"development":[2],"of":[3,23,26,42,55,92,104,117,125,137,154,158,182],"immune":[4,62,183],"checkpoint":[5,46,184],"inhibitors":[6,47,94,185],"targeting":[7],"cytotoxic":[8],"T-lymphocyte":[9],"antigen":[10],"4":[11],"(CTLA-4)":[12],"and":[13,28,33,64,98,119,147,197,207,215,217],"programmed":[14],"cell":[15],"death-1":[16],"(PD-1)":[17],"has":[18,100,121],"significantly":[19],"improved":[20],"the":[21,135,138],"treatment":[22,136,156,208],"a":[24,40,101,122,201],"variety":[25,41],"cancers":[27],"led":[29],"to":[30,73,195,211,219],"US":[31],"Food":[32],"Drug":[34],"Administration":[35],"approvals":[36],"for":[37],"patients":[38],"with":[39,82,107,160,173],"malignant":[43],"neoplasms.":[44],"Immune":[45],"enhance":[48],"antitumor":[49],"immunity":[50],"by":[51],"blocking":[52],"negative":[53],"regulators":[54],"T-cell":[56],"function":[57],"that":[58,109],"exist":[59],"both":[60],"on":[61,65],"cells":[63],"tumor":[66],"cells.":[67],"Although":[68],"these":[69],"agents":[70,165],"can":[71,78],"lead":[72],"remarkable":[74],"responses,":[75],"their":[76],"use":[77,91,181],"also":[79],"be":[80,193],"associated":[81],"unique":[83],"immune-related":[84],"adverse":[85],"effects":[86],"(irAEs).":[87],"OBSERVATIONS:":[88],"In":[89],"general,":[90],"PD-1":[93],"such":[95,112,166],"as":[96,113,130,167],"nivolumab":[97,118],"pembrolizumab":[99],"lower":[102],"incidence":[103],"irAEs":[105,126,141,170,199],"compared":[106],"those":[108],"block":[110],"CTLA-4":[111],"ipilimumab.":[114],"combination":[116],"ipilimumab":[120],"higher":[123],"rate":[124],"than":[127],"either":[128],"approach":[129],"monotherapy.":[131],"Consensus":[132],"guidelines":[133],"regarding":[134],"most":[139,169],"common":[140],"including":[142],"rash,":[143],"colitis,":[144],"hepatitis,":[145],"endocrinopathies,":[146],"pneumonitis":[148],"have":[149],"been":[150],"established.":[151],"mainstay":[153],"irAE":[155],"consists":[157],"immunosuppression":[159],"corticosteroids":[161],"or":[162],"other":[163],"immunosuppressant":[164],"infliximab;":[168],"will":[171,191],"resolve":[172],"appropriate":[174],"management.":[175],"CONCLUSIONS":[176],"AND":[177],"RELEVANCE:":[178],"clinical":[180],"is":[186,222],"expanding":[187],"rapidly.":[188],"Oncology":[189],"practitioners":[190],"therefore":[192],"required":[194],"recognize":[196],"manage":[198],"in":[200],"growing":[202],"patient":[203,213],"population.":[204],"Early":[205],"recognition":[206],"are":[209],"essential":[210],"prevent":[212],"morbidity":[214],"mortality,":[216],"adherence":[218],"established":[220],"algorithms":[221],"recommended.":[223]},"counts_by_year":[{"year":2026,"cited_by_count":37},{"year":2025,"cited_by_count":45},{"year":2024,"cited_by_count":66},{"year":2023,"cited_by_count":79},{"year":2022,"cited_by_count":88},{"year":2021,"cited_by_count":101},{"year":2020,"cited_by_count":123},{"year":2019,"cited_by_count":110},{"year":2018,"cited_by_count":82},{"year":2017,"cited_by_count":72},{"year":2016,"cited_by_count":9}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-07-22T00:00:00"}